BioSpace News Archive

Business

Kaleido Biosciences Announces Appointment of Wendy Arnold as Senior Vice President, Human Resources

Ms. Arnold, who brings more than 20 years of experience in human resources to Kaleido, will report directly to chief executive officer and chair, Michael Bonney.

January 3, 2018
·
2 min read
Pharm Country

Janssen Release: Landmark Schizophrenia Data That Bring Hope in Breaking the Cycle of Hospitalization and Incarceration Receive FDA Approval for Inclusion in INVEGA SUSTENNA (paliperidone palmitate) Label

Janssen today announced INVEGA SUSTENNA, a once-monthly schizophrenia treatment, is the first and only antipsychotic to have the FDA approve the inclusion of real-world data in its product labeling.

January 3, 2018
·
14 min read
Policy

Perrigo Announces Tentative FDA Approval for the Generic Version of Prolensa Ophthalmic Solution 0.07%

Perrigo previously settled litigation with Bausch & Lomb for this product.

January 3, 2018
·
4 min read
BioMidwest

Medical Design Engineers’ Adhesive Selection Process Made Easier With New 3M Product Selector Tool

The product selector tool will be available to demo at CES 2018 in Las Vegas from January 9-12, 2018 in the 3M booth located in Sands, Halls A-D; 43517 Health & Wellness Marketplace.

January 3, 2018
·
3 min read
Drug Development

Cytokinetics Announces Progress Against Vision 2020

Results from four clinical trials of CK-2127107 expected in 2018.

January 3, 2018
·
10 min read
Business

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter 2017 Financial Results

The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive VP and CFO.

January 3, 2018
·
1 min read
FDA

FDA Green Lights Zimmer Biomet’s Sidus Stem-Free Shoulder System

The Sidus system will be available in the United States beginning in the First Quarter of 2018.

January 3, 2018
·
3 min read
Policy

Five Prime Therapeutics Submits Investigational New Drug Application for Novel B7-H4 Antibody FPA150

Dual mechanism of action blocks a T cell checkpoint pathway and delivers enhanced ADCC against B7-H4-expressing tumor cells

January 3, 2018
·
4 min read
Shanghai Institute of Materia Medica: Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery

Recently, scientists at SIMM determined the crystal structure of GCGR in complex with a glucagon analogue and partial agonist NNC1702.

January 3, 2018
·
3 min read
Policy

CanniMed Therapeutics Inc.'s US Subsidiary Applies for State of Michigan Licenses for Medical Cannabis Production and Processing

CanniMed Therapeutics Inc., through its wholly owned subsidiary SubTerra LLC, has applied for State of Michigan licenses for the production and processing of medical cannabis.

January 3, 2018
·
6 min read